China Biologic Products, Inc. 4
4 · China Biologic Products, Inc. · Filed Nov 12, 2014
Insider Transaction Report
Form 4
Liu Wenfang
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2014-11-10−500→ 19,500 totalExercise: $17.00From: 2011-08-27Exp: 2021-02-27→ Common stock (500 underlying) - Sale
Common stock
2014-11-10$62.75/sh−500$31,375→ 7,080 total - Sale
Common stock
2014-11-10$62.75/sh−7,080$444,270→ 0 total - Exercise/Conversion
Common stock
2014-11-10$17.00/sh+500$8,500→ 7,580 total
Footnotes (2)
- [F1]Represents 500 shares of common stock (the "Sold Common Stock") sold on the open market for $62.75 per share on November 10, 2014. The Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 2 below for further details on the relevant stock options.
- [F2]Represents previously reported stock options to purchase 20,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's equity incentive plan, pursuant to a stock option agreement dated February 27, 2011, half of which will vest on August 27, 2011, and the remainder of which will vest on February 27, 2012.